Doctor's Program
Gwangju Institute of Science and Technology
Gwangju, Kwangju-jikhalsi, Republic of Korea
She is a Ph.D. candidate in the School of Materials Science and Engineering at the Gwangju Institute of Science and Technology (GIST), where she also earned her B.S. and M.S. degrees. Her research focuses on engineering therapeutic proteins and antibody fragments to enhance their stability and in vivo performance. Currently, she is working on the development of recombinant antibody fragment–based drug conjugates equipped with albumin-binding domains to improve pharmacokinetics and antitumor efficacy.
Disclosure information not submitted.
Albubody platform for enhanced anti-tumor efficacy of scfv-based drug conjugates
Thursday, July 17, 2025
5:57 PM - 6:08 PM EDT
